Browse 156 HPV clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
HPV is so common that most sexually active people get it at some point, and the body usually clears it without anyone knowing. When it lingers, certain types can cause cancer years later, including more than 90 percent of cervical cancers and most cancers of the throat. A vaccine that prevents these infections has been available since 2006. The vaccine does not treat an infection that is already there, and trials are testing therapeutic vaccines and treatments that clear HPV and precancer before it becomes cancer.
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Jacksonville FL, Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05541016
Phase 2, Recruiting
Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
for
HPV-Negative Squamous Cell Carcinoma
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06005324
Phase 1, Recruiting
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06662058
Recruiting
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand
for
HSIL, High Grade Squamous Intraepithelial Lesions, Anal Cancer,
Location: New York NY
Sponsor: Stephen E. Goldstone
Sex: All
Age: 18 - 70+
Code: NCT03302858
Phase 2, Recruiting
Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
for
HPV-Related Squamous Cell Carcinoma
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT04988074
Phase 2, Recruiting
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers